barbituric acid has been researched along with tetradecanoylphorbol acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, RA; Leidenheimer, NJ; Whiting, PJ | 1 |
| Boehler, M; Garczarczyk, D; Gruber, P; Hauser, N; Hofmann, J; Kirchmair, J; Langer, T; Rechfeld, F | 1 |
2 other study(ies) available for barbituric acid and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Activation of calcium-phospholipid-dependent protein kinase enhances benzodiazepine and barbiturate potentiation of the GABAA receptor.
Topics: Animals; Barbiturates; Benzodiazepines; Chlorides; Electrophysiology; Enzyme Activation; Oocytes; Protein Kinase C; Receptors, GABA-A; Recombinant Proteins; Tetradecanoylphorbol Acetate; Xenopus laevis | 1993 |
Barbituric acid derivative BAS 02104951 inhibits PKCε, PKCη, PKCε/RACK2 interaction, Elk-1 phosphorylation in HeLa and PKCε and η translocation in PC3 cells following TPA-induction.
Topics: Animals; Barbiturates; Cell Line; Enzyme Inhibitors; ets-Domain Protein Elk-1; Fluorescent Antibody Technique; HeLa Cells; Humans; Phosphorylation; Protein Binding; Protein Kinase C; Protein Kinase C-epsilon; Rats; Tetradecanoylphorbol Acetate | 2011 |